CRBP - Corbus Pharmaceuticals Holdings, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
433.96M
Enterprise Value 3
387.43M
Trailing P/E
N/A
Forward P/E 1
-3.69
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
12.23
Price/Book (mrq)
14.65
Enterprise Value/Revenue 3
10.91
Enterprise Value/EBITDA 6
-5.79

Trading Information

Stock Price History

Beta (5Y Monthly) 1.80
52-Week Change 32.33%
S&P500 52-Week Change 325.78%
52 Week High 39.11
52 Week Low 34.18
50-Day Moving Average 35.82
200-Day Moving Average 35.44

Share Statistics

Avg Vol (3 month) 3728.53k
Avg Vol (10 day) 3898.26k
Shares Outstanding 564.67M
Float 56.14M
% Held by Insiders 15.49%
% Held by Institutions 148.45%
Shares Short (Dec 30, 2019) 415.26M
Short Ratio (Dec 30, 2019) 425.38
Short % of Float (Dec 30, 2019) 425.93%
Short % of Shares Outstanding (Dec 30, 2019) 423.59%
Shares Short (prior month Nov 28, 2019) 415.77M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin -175.17%
Operating Margin (ttm)-190.17%

Management Effectiveness

Return on Assets (ttm)-65.25%
Return on Equity (ttm)-171.50%

Income Statement

Revenue (ttm)35.5M
Revenue Per Share (ttm)0.57
Quarterly Revenue Growth (yoy)137.40%
Gross Profit (ttm)-43.79M
EBITDA -66.88M
Net Income Avi to Common (ttm)-62.18M
Diluted EPS (ttm)-1.00
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)54.85M
Total Cash Per Share (mrq)0.85
Total Debt (mrq)8.33M
Total Debt/Equity (mrq)28.09
Current Ratio (mrq)1.88
Book Value Per Share (mrq)0.46

Cash Flow Statement

Operating Cash Flow (ttm)-37.22M
Levered Free Cash Flow (ttm)-18.74M